Brimonidine: Clinical Trials

4 trials of Brimonidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow Brimonidine: new trials by email Literature Review of Brimonidine trials Research Report on Brimonidine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Brimonidine - Presbyopia, Refractive Error
Phase 3CompletedLENZ Therapeutics, Inc4692022-12-192026-05-13
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Brimonidine, placebo - Rosacea
Phase 3CompletedActavis Inc.4622014-07-012020-01-14
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
COLIRIOBCN070660, Placebo, Brimonidine - Diabetic Retinopathy
Phase 2 / Phase 3CompletedBCN Peptides4502013-02-012016-01-12
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
brimonidine - Glaucoma, Ocular Hypertension
Phase 3CompletedAllergan2072005-01-012011-05-30

Conditions studied

Diabetic Retinopathy (1)  ·  Eye Diseases (1)  ·  Glaucoma (1)  ·  Myopia (1)  ·  Ocular Hypertension (1)  ·  Presbyopia (1)  ·  Refractive Errors (1)  ·  Rosacea (1)

Sponsors

Actavis Inc. (1)  ·  Allergan (1)  ·  BCN Peptides (1)  ·  LENZ Therapeutics, Inc (1)

Countries

United States (2)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Kris Gambelin, BS (1)  ·  Nageshwar R Thudi, Ph.D. (1)

Results publications

PMID 18534052, PMID 28663190, PMID 28785768